A Systematic Review of Studies That Aim to Determine Which Outcomes to Measure in Clinical Trials in Children
暂无分享,去创建一个
Paula R Williamson | P. Williamson | R. Smyth | I. Sinha | Rosalind L Smyth | L. Jones | Ian Sinha | Leanne Jones | Rosalind L. Smyth | Ian Sinha | Paula R. Williamson | Leanne Jones
[1] Edmund V Capparelli,et al. Summary Proceedings From the Neonatal Pain-Control Group , 2006, Pediatrics.
[2] D. Felson,et al. Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.
[3] R. Clancy,et al. Summary proceedings from the neurology group on neonatal seizures. , 2006, Pediatrics.
[4] T. Boat,et al. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. , 1994, The Journal of pediatrics.
[5] G. Pearson,et al. Summary Proceedings From the Cardiology Group on Postoperative Cardiac Dysfunction , 2006, Pediatrics.
[6] D. Altman,et al. Outcome selection bias in meta-analysis , 2005, Statistical methods in medical research.
[7] S. Bae,et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. , 2006, Arthritis and rheumatism.
[8] D. Isenberg,et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. , 2001, Rheumatology.
[9] Alexander J. Rothman,et al. Evolution of the biopsychosocial model: prospects and challenges for health psychology. , 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[10] P. Lachenbruch,et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. , 2004, Arthritis and rheumatism.
[11] W. Carlo,et al. Analgesia and anesthesia for neonates: study design and ethical issues. , 2005, Clinical therapeutics.
[12] G. Guyatt,et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. , 1997, The European respiratory journal.
[13] M. Essink‐bot,et al. Reliability and validity of the short form of the child health questionnaire for parents (CHQ-PF28) in large random school based and general population samples , 2004, Journal of Epidemiology and Community Health.
[14] M. Clarke,et al. Evaluating maternity care: a core set of outcome measures. , 2007, Birth.
[15] R. Nosadini,et al. Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.
[16] Linda S. Deal,et al. Age-Specific Questionnaires Distinguish GERD Symptom Frequency and Severity in Infants and Young Children: Development and Initial Validation , 2005, Journal of pediatric gastroenterology and nutrition.
[17] B. Short,et al. Summary Proceedings From the Cardiology Group on Cardiovascular Instability in Preterm Infants , 2006, Pediatrics.
[18] J. Osborne,et al. Towards an international consensus on definitions and standardised outcome measures for therapeutic trials (and epidemiological studies) in West syndrome , 2001, Brain and Development.
[19] Ellen Leibenluft,et al. Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder : Report of a Consensus , 2004 .
[20] A. Lewis. Group Child Interviews as a Research Tool , 1992 .
[21] D. Wade,et al. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. , 2000, Stroke.
[22] G. Molenberghs,et al. A perspective on surrogate endpoints in controlled clinical trials , 2004, Statistical methods in medical research.
[23] D. DeMets,et al. Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.
[24] P. Lachenbruch,et al. Defining Clinical Improvement in Adult and Juvenile Myositis. , 2003, The Journal of rheumatology.
[25] W. LaFrance,et al. Nonepileptic seizures treatment workshop summary , 2006, Epilepsy & Behavior.
[26] J. Osborne,et al. A Proposal for Case Definitions and Outcome Measures in Studies of Infantile Spasms and West Syndrome: Consensus Statement of the West Delphi Group , 2004, Epilepsia.
[27] Emma Pitchforth,et al. Delphi method and nominal group technique in family planning and reproductive health research , 2006, Journal of Family Planning and Reproductive Health Care.
[28] K. Minden,et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. , 2005, Arthritis and rheumatism.
[29] Mike Clarke,et al. Standardising outcomes for clinical trials and systematic reviews , 2007, Trials.
[30] A. Griffiths,et al. A Review of Activity Indices and End Points for Clinical Trials in Children with Crohn's Disease , 2005, Inflammatory bowel diseases.
[31] S. Leeder,et al. The asthma health outcome indicators study , 1996, Australian and New Zealand journal of public health.
[32] R. Holloway,et al. Clinical trial end points: on the road to nowhere? , 2002, Neurology.
[33] L. Rider. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. , 2002, Rheumatic diseases clinics of North America.
[34] D. Altman,et al. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors , 2005, BMJ : British Medical Journal.
[35] Norman Crolee Dalkey,et al. An experimental study of group opinion , 1969 .
[36] P. Williamson,et al. Bias in meta‐analysis due to outcome variable selection within studies , 2000 .
[37] B. Leroux,et al. Issues in design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children. , 2002, Controlled clinical trials.
[38] A. Randolph,et al. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[39] P. Pharoah. Impairment, disability, and handicap. , 1990, Archives of disease in childhood.
[40] D. Mattison,et al. The Newborn Drug Development Initiative , 2006, Pediatrics.
[41] W. Kuis,et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. , 2003, Rheumatology.
[42] H. Kraemer,et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.
[43] P. Tugwell,et al. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. , 1993, The Journal of rheumatology.
[44] C. Oddis. Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies , 2005, Current rheumatology reports.
[45] N. Finer,et al. Summary Proceedings From the Apnea-of-Prematurity Group , 2006, Pediatrics.